Literature DB >> 27905452

Failed Alzheimer's trial does not kill leading theory of disease.

Alison Abbott, Elie Dolgin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27905452     DOI: 10.1038/nature.2016.21045

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  44 in total

Review 1.  (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.

Authors:  Robert E Becker; Nigel H Greig; Debomoy K Lahiri; Joseph Bledsoe; Sarah Majercik; Clive Ballard; Dag Aarsland; Lon S Schneider; Douglas Flanagan; Ramprakash Govindarajan; Mary Sano; Luigi Ferrucci; Dimitrios Kapogiannis
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 2.  Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Authors:  Madhav Thambisetty
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

3.  Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.

Authors:  Roger N Rosenberg; Min Fu; Doris Lambracht-Washington
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

4.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

Review 5.  Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Steffen E Storck; Claus U Pietrzik
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

Review 6.  Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

Authors:  Paul J Carter; Greg A Lazar
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

7.  Neurotrophic Factors Mediated Activation of Astrocytes Ameliorate Memory Loss by Amyloid Clearance after Transplantation of Lineage Negative Stem Cells.

Authors:  P Bali; A Banik; B Nehru; Akshay Anand
Journal:  Mol Neurobiol       Date:  2019-06-27       Impact factor: 5.590

8.  Computational Analysis for the Rational Design of Anti-Amyloid Beta (Aβ) Antibodies.

Authors:  D'Artagnan Greene; Theodora Po; Jennifer Pan; Tanya Tabibian; Ray Luo
Journal:  J Phys Chem B       Date:  2018-04-16       Impact factor: 2.991

Review 9.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

10.  Profiling the Serum Protein Corona of Fibrillar Human Islet Amyloid Polypeptide.

Authors:  Emily H Pilkington; Ove J R Gustafsson; Yanting Xing; Juan Hernandez-Fernaud; Cleidi Zampronio; Aleksandr Kakinen; Ava Faridi; Feng Ding; Paul Wilson; Pu Chun Ke; Thomas P Davis
Journal:  ACS Nano       Date:  2018-05-16       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.